Roche Moved Asia HQ From Australia To China For Sales Potential
This article was originally published in PharmAsia News
Executive Summary
Shanghai's attraction for high-tech companies also was a magnet for Roche when it considered a regional headquarters in Asia, the firm's Asia Pacific head says
|
Shanghai's attraction for high-tech companies also was a magnet for Roche when it considered a regional headquarters in Asia, the firm's Asia Pacific head says. Luke Miels said the move from Australia to China was made in part because the Chinese market for the firm's drugs now ranks with the United States, Germany and other developed nations. Miels said Shanghai also was chosen because of the education level of the workforce, its infrastructure and favorable views toward investment and foreign firms. (Click here for more) "City Lures Roche As Base For HQ" - Shanghai Daily (China) (1/15/10) |